Skip to content

The relationship between blood concentration and clinical efficacy of ketamine in protecting postoperative cognitive function in elderly patients

The relationship between blood concentration and clinical efficacy of ketamine in protecting postoperative cognitive function in elderly patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090414
Enrollment
Unknown
Registered
2024-09-29
Start date
2024-02-19
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Interventions

EC2:Anesthesia induction begins with continuous infusion of 0.2mg/kg/h ketamine, for 1 hour
EC4:Anesthesia induction begins with continuous infusion of 0.4mg/kg/h ketamine, for 1 hour
control group:none

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age greater than or equal to 60 years old; 2. American Society of Anesthesiologists (ASA) physical condition grades I-III; 3. Patients who experience discomfort in the lower back due to various reasons and require surgical treatment; 4. Surgical duration = 1.5 hours.

Exclusion criteria

Exclusion criteria: 1. Age under 60 years old 2. Obesity (BMI>40); 3. Abnormal cardiac function; 4. Severe liver and kidney dysfunction or diabetes; 5. Having mental illness, inability to cooperate, taking psychotropic drugs, and difficulty in verbal communication; 6. Severe coagulation dysfunction; 7. History of severe drug allergies; 8. Lost or withdrawn from the experiment.

Design outcomes

Primary

MeasureTime frame
MMSE;

Secondary

MeasureTime frame
extubation;Intraoperative Use of Vasoactive Drugs;Hospitalization duration;RASS;

Countries

CHINA

Contacts

Public ContactXu Tongzhang

The Second Affiliated Hospital of Wenzhou Medical University

Amitong@163.com+86 138 6888 3366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026